Q32 Bio Inc. (QTTB) — Financial statements
Income statement, balance sheet, and cash flow for Q32 Bio Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 54 | 0.00↑100.0% | -7↓200.0% | 7↓80.4% | 34 | |
| Cost of Revenue | 0.39↓19.7% | 0.49 | 0.00 | 0.00↓100.0% | 10 | |
| Gross Profit | 53↑11054.0% | -0.49↑92.7% | -7↓200.0% | 7↓72.8% | 24 | |
| Operating Expenses | ||||||
| R&D Expenses | 19↓60.2% | 48↑51.7% | 32↓11.4% | 36↓61.5% | 93 | |
| General & Administrative Expenses | 18↓1.6% | 18↑81.9% | 10↓1.9% | 10↑48.8% | 7 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 18↑1.2% | 17↑76.9% | 10↓1.9% | 10↓63.1% | 27 | |
| Other Expenses | -0.39 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 36↓44.5% | 66↑57.7% | 42↓9.3% | 46↓61.9% | 120 | |
| Total Costs & Expenses | 37↓44.3% | 66↑58.9% | 42↓9.3% | 46↓64.7% | 130 | |
| Operating Results | ||||||
| Operating Income | 17↑125.6% | -66↓37.0% | -48↓23.0% | -39↑59.1% | -96 | |
| Depreciation & Amortization | 0.39↓19.7% | 0.49↓2.4% | 0.50↑34.9% | 0.37↓96.1% | 10 | |
| EBITDA | 17↑138.2% | -45↑5.1% | -48↓22.9% | -39↑54.9% | -86 | |
| EBIT | 17↑136.9% | -46↑5.1% | -48↓23.0% | -39↑59.0% | -96 | |
| Interest & Other Income | ||||||
| Net Interest Income | 1↓69.4% | 4 | 0.00 | 0.00↓100.0% | 0.19 | |
| Interest Income | 2↓43.6% | 4 | 0.00 | 0.00↓100.0% | 0.19 | |
| Interest Expense | 1↑266.7% | 0.30 | 0.00 | 0.00 | 0.00 | |
| Non-Operating Income | 0.00↑100.0% | -20 | 0.00 | 0.00↑100.0% | -0.19 | |
| Other Income / Expenses | 13↓29.7% | 18↑455.7% | -5↓46.8% | -4↓2003.8% | 0.19 | |
| Income Before Tax | 30↑162.5% | -48↑10.7% | -53↓25.0% | -43↑55.4% | -96 | |
| Income Tax Expense | 0.00↓100.0% | 0.02↓93.4% | 0.32↑412.9% | 0.06 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 30↑162.5% | -48↑11.2% | -54↓25.5% | -43↑55.3% | -96 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 30↑162.5% | -48↑11.2% | -54↓25.5% | -43↑55.3% | -96 | |
| Bottom-Line Net Income | 30↑146.9% | -64↓18.2% | -54↓25.5% | -43↑55.3% | -96 | |
| EPS (Basic) | 2.42↑147.3% | -5.12↑69.3% | -16.70↓24.4% | -13.42↑57.0% | -31.18 | |
| EPS (Diluted) | 2.42↑136.8% | -6.58↑60.6% | -16.70↓24.4% | -13.42↑57.0% | -31.18 | |
| Weighted Average Shares | 12↑0.8% | 12↑279.0% | 3↑0.9% | 3↑3.8% | 3 | |
| Weighted Average Diluted Shares | 12↑1.0% | 12↑279.0% | 3↑0.9% | 3↑3.8% | 3 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.